Puma Biotechnology retracts defamatory statements about Dr. Frederic Eshelman after court ruling

PUMA BIOTECHNOLOGY, INC.

Retracts 2016 investor-presentation statements implying Dr. Eshelman was fired from PPD and involved in clinical fraud.
Fourth Circuit affirmed liability verdict on June 23, 2021, but vacated excessive damages award.
Company states no portion of presentation should be interpreted to suggest Eshelman fired or implicated in fraud.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.